2026 жылында Италияда өкпе рагын емдеу үшін операцияға бойынша ең жақсы бағалар мен клиникалар туралы біліңіз

Lung cancer surgery in Italy is exceptionally safe and performed by board-certified thoracic surgeons following European Union standards. High-volume centers reported 30-day mortality rates as low as 0.2% for robotic procedures. Specialized surgeons often hold European Board of Thoracic and Cardiovascular Surgery certifications and utilize advanced Video-Assisted Thoracoscopic Surgery or Robotic-Assisted Thoracic Surgery systems.

• Surgeon credentials: Specialists must complete 5-year postgraduate training in thoracic diagnostics and minimally invasive techniques.
• Safety benchmarks: Large research hospitals maintain efficacy rates between 85% and 90% for early-stage cases.
• Advanced technology: Facilities like San Raffaele utilize robotic Da Vinci Xi systems for precision lung resections.
• Recovery times: Minimally invasive VATS or robotic surgery reduces recovery to 2–4 weeks for most patients.

Bookimed Expert Insight: While private clinics offer faster scheduling, Italy's research hospitals known as IRCCS provide a unique advantage. These centers combine clinical care with active research. At San Raffaele, surgeons like Dr. Giampiero Negri lead units focused specifically on mini-invasive surgery. This specialized focus ensures patients access the latest techniques before they become standard elsewhere.

Patient Consensus: Patients emphasize selecting high-volume centers in northern Italy, where surgical infrastructure is most advanced. Many noted the significant difference in recovery speed when choosing robotic approaches over traditional open surgery.

Surgical management for early-stage lung cancer in Italy centers on lobectomy and segmentectomy performed via minimally invasive techniques. Recognized procedures include Video-Assisted Thoracoscopic Surgery (VATS) and Robotic-Assisted Thoracic Surgery (RATS), which are standard at high-volume centers to ensure faster recovery and lower complication rates.

• Gold standard resection: Lobectomy removes one lung lobe and is preferred for localized Stage I-II tumors.
• Sublobar options: Segmentectomy or wedge resection preserves lung tissue for tumors under 2 cm.
• Minimally invasive approaches: VATS and robotic systems like Da Vinci Xi reduce hospital stays to 2–5 days.
• Mandatory staging: Italian protocols require systematic lymphadenectomy to ensure accurate cancer staging during surgery.

Bookimed Expert Insight: Italian research hospitals like San Raffaele emphasize research-driven care, where surgeons often prioritize anatomical segmentectomy over lobectomy for very small tumors. Dr. Giampiero Negri at San Raffaele leads specialized units focusing specifically on these mini-invasive techniques. Choosing a facility with IRCCS status ensures access to these advanced, lung-preserving protocols usually reserved for academic trials.

Patient Consensus: Patients emphasize requesting VATS or robotic options to avoid the long recovery associated with open thoracotomy. They often recommend starting daily walking immediately after surgery to manage pain and speed up discharge.

Prepare for lung cancer surgery in Italy by focusing on pulmonary rehabilitation and smoking cessation at least 8 weeks prior. Recovery involves initial chest tube management followed by a 2-3 month transition back to full activity under the care of specialized thoracic surgeons.

• Pre-operative preparation: Walk 5 km daily to build lung capacity and improve surgical outcomes.
• Smoking cessation: Quit 8 weeks early to boost healing rates and reduce complications.
• Minimally invasive approach: Surgeons in Milan often use mini-invasive thoracic surgery to accelerate recovery.
• Acute post-surgery: Use an incentive spirometer hourly while awake to actively prevent pneumonia.
• Hospital stay: Expect chest tube removal within 3 to 5 days after the operation.

Bookimed Expert Insight: Italian centers like San Raffaele emphasize research-driven recovery protocols. Dr. Giampiero Negri specializes in mini-invasive techniques which typically result in shorter hospital stays. Patients should confirm if their procedure uses these advanced methods to plan for a faster return home.

Patient Consensus: Many survivors stress that fatigue peaks around weeks 3 to 6. They recommend using a shower chair and enlisting home help for the first month to manage daily tasks easily.

Visible scarring after lung cancer surgery in Italy depends on the surgical approach. Minimally invasive techniques leave 1-4 small marks, while open surgery results in a single, longer curved incision. Most scars fade from red or purple to pale, flat lines within 12-24 months.

• VATS incisions: These consist of 3-5 small ports, each measuring only 1-2 centimeters.
• Thoracotomy scars: Open surgery creates a 6-10 inch curved line under the armpit.
• Minimally invasive appearance: Small port scars eventually resemble large freckles or faint skin indentations.
• Open surgery maturation: Large incisions remain red for 6 months before flattening into pale lines.

Bookimed Expert Insight: Italian research hospitals like San Raffaele specialize in mini-invasive thoracic surgery, which significantly reduces visible scarring. Large-volume centers performing 52,000+ annual operations often use VATS lobectomy. This technique places smaller incisions in natural skin folds or under the arm where they remain hidden by clothing.

Patient Consensus: Patients report that side and back scars are largely invisible in daily life. Using silicone sheets and sunblock religiously for 1 year helps scars fade much faster into nearly imperceptible marks.

International patients usually stay in Italy for 3 to 4 weeks for lung cancer surgery. This duration covers pre-operative staging, 5 to 7 days of hospitalization, and post-operative monitoring. Italian surgeons require a clear chest X-ray before approving air travel home.

• Hospitalization stay: Patients typically spend 5 to 7 days in the medical facility after surgery.
• Clinical monitoring: Surgeons require 7 to 10 days of local stay after hospital discharge.
• Air travel safety: Most specialists advise waiting at least 2 weeks before flying to avoid complications.
• Total time frame: Plan for 21 to 28 days to complete surgery and initial recovery locally.

Bookimed Expert Insight: Italian research hospitals like Ospedale San Raffaele perform over 52,000 operations annually. Their high surgical volume often leads to standardized, efficient recovery protocols. Patients choosing IRCCS-accredited facilities in Rome or Milan benefit from integrated research and clinical care.

Patient Consensus: Patients emphasize that staying near the clinic for a full week post-discharge is vital. This ensures stability and allows for the necessary final chest X-rays before departing Italy.

Milan and Rome are the primary hubs for lung cancer surgery in Italy. Top-tier institutions like San Raffaele in Milan combine research with clinical care under IRCCS accreditation. Leading surgeons in these cities specialize in mini-invasive thoracic surgery and complex lobectomy procedures.

• Regional expertise: Northern Italy, specifically Milan, is the primary center for advanced oncology care.
• San Raffaele: Performs over 52,000 operations annually as a leading European research hospital.
• Ospedale San Carlo di Nancy: Provides specialized surgical services in Rome within the GVM Care network.
• Specialized techniques: Italian centers focus on mini-invasive thoracic surgery to improve postoperative recovery.

Bookimed Expert Insight: Milan centers offer a distinct advantage for international patients due to their IRCCS status. This certification ensures surgeons like Giampiero Negri at San Raffaele apply the latest research. Choosing a university-affiliated hospital here guarantees access to a multidisciplinary team including specialist pathologists.

Patient Consensus: Patients emphasize that university teaching hospitals in Milan and Rome provide the most reliable thoracic programs. Many suggest confirming a surgeon's specific case volume for lung cancer before scheduling.